• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA grants de novo clearance to AI Biomed, FluoOptics parathyroid tissue detection devices

FDA grants de novo clearance to AI Biomed, FluoOptics parathyroid tissue detection devices

November 6, 2018 By Fink Densford

FDA

The FDA today granted de novo clearance to parathyroid tissue detection devices from both Fluoptics and AI Biomed.

The systems are intended to provide the real-time location of parathyroid tissue during surgical procedures including thyroidectomy and parathyroidectomy, the federal watchdog said.

FluOptics won approval for its Fluobeam 800 clinic imaging device which can be used as a companion to assist in locating parathyroid tissue during surgery, the FDA said. Parathyroid tissue emits a fluorescent glow when exposed to the Fluobeam’s light source, which eliminates the need for a contrast agent.

The system previously won clearance as an imaging system to capture and view fluorescent images for visually assessing blood flow as an adjunctive method of evaluating tissue perfusion, the agency said.

Approval came based on data from five peer-reviewed published studies, including a trial that compared postoperative hypocalcemia (PH) rates post-removal of parathyroid tissue. Results indicated that in 93 patients who underwent procedures with the device, 5% experienced fluctuating PH levels following surgery, lower than the 21% reported on 153 patients who underwent surgery without the device, the agency said.

AI Biomed won clearance for its Parathyroid Detection PTeye system, which is intended to aid in detecting parathyroid tissue by using a probe that emits fluorescent light. The system provides both audio and visual displays to indicate the presence of parathyroid tissue, the FDA said.

The system won approval based on data from a single-blinded study of 81 patients treated with the device, with data indicating that the PTeye system could correctly identify parathyroid tissue as compared to histology 93% of the time, and the absence of such tissue as compared to intraoperative expert visualization 97% of the time. The overall accuracy of the device was reported as 96%, the FDA reported.

“For some patients with parathyroid disease, treatment may mean a surgical procedure. Real-time identification of parathyroid tissue during surgery can provide surgeons with valuable information to help preserve healthy tissue or to remove diseased tissue,” FDA Center for Devices and Radiological Health Division of Surgical Devices director Dr. Binita Ashar said in a press release.

Filed Under: Imaging, Regulatory/Compliance, Surgical Tagged With: aibiomed, Fluoptics

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy